Cargando…
Effects of Intravascular Photobiomodulation on Insomnia, Muscle Soreness, and Biochemistry Profiles: An Eight-Year Retrospective Cohort
Background: Although cognitive-behavioral therapy is the first-line treatment for insomnia, pharmacotherapy is often prescribed to treat insomnia and related symptoms. In addition, muscle relaxants are commonly prescribed to alleviate muscle soreness when the pain is unbearable. However, pharmacothe...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305368/ https://www.ncbi.nlm.nih.gov/pubmed/37374210 http://dx.doi.org/10.3390/medicina59061006 |
_version_ | 1785065717015511040 |
---|---|
author | Lin, Yen-Po Ding, Ruei-Sian Yin, Chun-Hao Chen, Yao-Shen Chen, Jin-Shuen Chang, Shin-Tsu |
author_facet | Lin, Yen-Po Ding, Ruei-Sian Yin, Chun-Hao Chen, Yao-Shen Chen, Jin-Shuen Chang, Shin-Tsu |
author_sort | Lin, Yen-Po |
collection | PubMed |
description | Background: Although cognitive-behavioral therapy is the first-line treatment for insomnia, pharmacotherapy is often prescribed to treat insomnia and related symptoms. In addition, muscle relaxants are commonly prescribed to alleviate muscle soreness when the pain is unbearable. However, pharmacotherapy can lead to numerous side effects. The non-drug strategy intravascular laser irradiation of blood (iPBM) has been advocated to improve pain, wound healing, blood circulation, and blood cell function to relieve insomnia and muscle soreness symptoms. Therefore, we assessed whether iPBM improves blood parameters and compared drug use before and after iPBM therapy. Methods: Consecutive patients who received iPBM therapy between January 2013 and August 2021 were reviewed. The associations between laboratory data, pharmacotherapies, and iPBM therapy were retrospectively analyzed. We compared patient characteristics, blood parameters, and drug use within the three months before the first treatment and the three months after the last treatment. We also compared the changes before and after treatment in patients who received ≥10 or 1–9 iPBM treatments. Result: We assessed 183 eligible patients who received iPBM treatment. Of them, 18 patients reported insomnia disturbance, and 128 patients reported pain in any part of their body. After the treatment, HGB and HCT significantly increased after treatment in both the ≥10 and 1–9 iPBM treatment groups (HGB p < 0.001 and p = 0.046; HCT p < 0.001 and p = 0.029, respectively). Pharmacotherapy analysis revealed no significant differences in drug use before and after treatment, though drug use tended to decrease after iPBM. Conclusions: iPBM therapy is an efficient, beneficial, and feasible treatment that increases HGB and HCT. While the results of this study do not support the suggestion that iPBM reduces drug use, further larger studies using symptom scales are needed to confirm the changes in insomnia and muscle soreness after iPBM treatment. |
format | Online Article Text |
id | pubmed-10305368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103053682023-06-29 Effects of Intravascular Photobiomodulation on Insomnia, Muscle Soreness, and Biochemistry Profiles: An Eight-Year Retrospective Cohort Lin, Yen-Po Ding, Ruei-Sian Yin, Chun-Hao Chen, Yao-Shen Chen, Jin-Shuen Chang, Shin-Tsu Medicina (Kaunas) Article Background: Although cognitive-behavioral therapy is the first-line treatment for insomnia, pharmacotherapy is often prescribed to treat insomnia and related symptoms. In addition, muscle relaxants are commonly prescribed to alleviate muscle soreness when the pain is unbearable. However, pharmacotherapy can lead to numerous side effects. The non-drug strategy intravascular laser irradiation of blood (iPBM) has been advocated to improve pain, wound healing, blood circulation, and blood cell function to relieve insomnia and muscle soreness symptoms. Therefore, we assessed whether iPBM improves blood parameters and compared drug use before and after iPBM therapy. Methods: Consecutive patients who received iPBM therapy between January 2013 and August 2021 were reviewed. The associations between laboratory data, pharmacotherapies, and iPBM therapy were retrospectively analyzed. We compared patient characteristics, blood parameters, and drug use within the three months before the first treatment and the three months after the last treatment. We also compared the changes before and after treatment in patients who received ≥10 or 1–9 iPBM treatments. Result: We assessed 183 eligible patients who received iPBM treatment. Of them, 18 patients reported insomnia disturbance, and 128 patients reported pain in any part of their body. After the treatment, HGB and HCT significantly increased after treatment in both the ≥10 and 1–9 iPBM treatment groups (HGB p < 0.001 and p = 0.046; HCT p < 0.001 and p = 0.029, respectively). Pharmacotherapy analysis revealed no significant differences in drug use before and after treatment, though drug use tended to decrease after iPBM. Conclusions: iPBM therapy is an efficient, beneficial, and feasible treatment that increases HGB and HCT. While the results of this study do not support the suggestion that iPBM reduces drug use, further larger studies using symptom scales are needed to confirm the changes in insomnia and muscle soreness after iPBM treatment. MDPI 2023-05-24 /pmc/articles/PMC10305368/ /pubmed/37374210 http://dx.doi.org/10.3390/medicina59061006 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lin, Yen-Po Ding, Ruei-Sian Yin, Chun-Hao Chen, Yao-Shen Chen, Jin-Shuen Chang, Shin-Tsu Effects of Intravascular Photobiomodulation on Insomnia, Muscle Soreness, and Biochemistry Profiles: An Eight-Year Retrospective Cohort |
title | Effects of Intravascular Photobiomodulation on Insomnia, Muscle Soreness, and Biochemistry Profiles: An Eight-Year Retrospective Cohort |
title_full | Effects of Intravascular Photobiomodulation on Insomnia, Muscle Soreness, and Biochemistry Profiles: An Eight-Year Retrospective Cohort |
title_fullStr | Effects of Intravascular Photobiomodulation on Insomnia, Muscle Soreness, and Biochemistry Profiles: An Eight-Year Retrospective Cohort |
title_full_unstemmed | Effects of Intravascular Photobiomodulation on Insomnia, Muscle Soreness, and Biochemistry Profiles: An Eight-Year Retrospective Cohort |
title_short | Effects of Intravascular Photobiomodulation on Insomnia, Muscle Soreness, and Biochemistry Profiles: An Eight-Year Retrospective Cohort |
title_sort | effects of intravascular photobiomodulation on insomnia, muscle soreness, and biochemistry profiles: an eight-year retrospective cohort |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305368/ https://www.ncbi.nlm.nih.gov/pubmed/37374210 http://dx.doi.org/10.3390/medicina59061006 |
work_keys_str_mv | AT linyenpo effectsofintravascularphotobiomodulationoninsomniamusclesorenessandbiochemistryprofilesaneightyearretrospectivecohort AT dingrueisian effectsofintravascularphotobiomodulationoninsomniamusclesorenessandbiochemistryprofilesaneightyearretrospectivecohort AT yinchunhao effectsofintravascularphotobiomodulationoninsomniamusclesorenessandbiochemistryprofilesaneightyearretrospectivecohort AT chenyaoshen effectsofintravascularphotobiomodulationoninsomniamusclesorenessandbiochemistryprofilesaneightyearretrospectivecohort AT chenjinshuen effectsofintravascularphotobiomodulationoninsomniamusclesorenessandbiochemistryprofilesaneightyearretrospectivecohort AT changshintsu effectsofintravascularphotobiomodulationoninsomniamusclesorenessandbiochemistryprofilesaneightyearretrospectivecohort |